EUCTR2006-006679-18-NOActive, not recruitingNot Applicable
Prostate Phytochemical & PUFA Intervention (PFPI)Norwegian title: Prostata Fytokjemikalie & PUFA Intervensjon (PFPI) - PFPI
niversity of Oslo, institute for basic medical sciences, department of nutrition.0 sitesStarted: January 18, 2007Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- Male
Inclusion Criteria
- •1.Histologically verified adenocarsinoma
- •2.pN0/NXM0 (TNM/UICC 2002) and at least one negative prognostic factor for HDR-BT or low-intermediate risk profile by radical prostatectomi.
- •3.PSA < 50 ng/mL+(Gleason score=>6) or T1c- T3a, prostatevolume < 50mL
- •4.Performance status 0-1
- •5.Normal leukocytecount og trombocytecount, Hb >11g/dl
- •6.Life expectancy > 5 år
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •1. Previous endocrine treatment
- •2. Insulindependent diabetes mellitus, vasculitis, inflammatory bowel disease etc. which might influence quality of life or radiotherapy.
- •3. Urinary retention, urinary incontinence, IPPS score <12 (HDR-BT patients).
Investigators
Similar Trials
Completed
Phase 1
Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer PatientsProstate CancerNCT00433797University of Oslo86
Completed
Phase 1
White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local TherapyProstate CancerNCT00779168City of Hope Medical Center36
Completed
Phase 2
Pilot study: Fosfomycin levels in prostate tissue after oral and iv administratioprostatitisprostate infection10004018NL-OMON44736HagaZiekenhuis30
Completed
Not Applicable
ycopene and Vitamin E in men with minimal prostate cancer and rising PSA after radical prostatectomy. A double blind randomised placebo controlled cross-over study.Minimal prostate cancer and rising PSA after radical prostatectomy.NL-OMON25453BASF Aktiengesellschaft.80
Recruiting
Not Applicable
Evaluation of therapeutic effect on prostate cancer patients with bone metastases using Bone Scan Index (BSI)Prostate cancer patients with bone metastasisJPRN-UMIN000011648Osaka University160